Top Markets
#1 Siren Siren +33.52%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.78%
#4 Ribbita by Virtuals Ribbita by Virtuals +18.13%
#5 PulseChain PulseChain +16.92%
#6 Bitway Bitway +16.57%
#7 Velvet Velvet +16.09%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.45%
#9 Perle Perle +15.21%
#10 KUB Coin KUB Coin +14.99%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
Classifica tra le azioni #30975
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
Prezzo delle azioni
$0.13577832
Capitalizzazione di mercato
$14.83M
Variazione (1 giorno)
-2.63%
Variazione (1 anno)
44.13%
Paese
CA
Scambia Pharmala Biotech Holdings Inc. (MDMA)

Categoria

Healthcare
Rapporto P/S per Pharmala Biotech Holdings Inc. (MDMA)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pharmala Biotech Holdings Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Pharmala Biotech Holdings Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE